These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15578952)

  • 21. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease.
    Morishita R; Aoki M; Kaneda Y
    Ann N Y Acad Sci; 2001 Dec; 947():294-301; discussion 301-2. PubMed ID: 11795277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
    Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
    Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.
    Hashiya N; Aoki M; Tachibana K; Taniyama Y; Yamasaki K; Hiraoka K; Makino H; Yasufumi K; Ogihara T; Morishita R
    Biochem Biophys Res Commun; 2004 Apr; 317(2):508-14. PubMed ID: 15063786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft.
    Cho WH; Lee SO; Kim HT; Ahn JD; Lee IK
    Transplant Proc; 2005; 37(1):77-9. PubMed ID: 15808553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates.
    Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M
    Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
    Osako MK; Nakagami H; Morishita R
    Curr Top Med Chem; 2012; 12(15):1603-7. PubMed ID: 22762556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.
    Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of decoy strategy].
    Morishita R; Ogihara T
    Nihon Rinsho; 1996 Sep; 54(9):2583-90. PubMed ID: 8890596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.
    Morishita R; Kaneda Y; Ogihara T
    BioDrugs; 2003; 17(6):383-9. PubMed ID: 14614761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.
    Tomita N; Morishita R; Yamamoto K; Higaki J; Dzau VJ; Ogihara T; Kaneda Y
    J Gene Med; 2002; 4(5):527-35. PubMed ID: 12221646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation.
    Morishita R; Higaki J; Tomita N; Aoki M; Moriguchi A; Tamura K; Murakami K; Kaneda Y; Ogihara T
    Hypertension; 1996 Mar; 27(3 Pt 2):502-7. PubMed ID: 8613193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing.
    Shimizu H; Nakagami H; Morita S; Tsukamoto I; Osako MK; Nakagami F; Shimosato T; Minobe N; Morishita R
    Antioxid Redox Signal; 2009 Sep; 11(9):2065-75. PubMed ID: 19186992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of NFkappaB inhibitor for arthritis].
    Tomita T; Kunugiza Y; Nomura K; Morimoto D; Kuroda S; Yoshikawa H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):71-6. PubMed ID: 19404004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
    Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
    Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
    Miyake T; Aoki M; Morishita R
    Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
    Tomita N; Morishita R; Tomita S; Gibbons GH; Zhang L; Horiuchi M; Kaneda Y; Higaki J; Ogihara T; Dzau VJ
    Gene Ther; 2000 Aug; 7(15):1326-32. PubMed ID: 10918504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.